After the data from CHAMPION, the watchman looks a bit worse for stroke prevention than I was anticipating
It remains a tool (and one with very limited use case) but it’s certainly not a panacea for stroke prevention in Afib
Some of my additional thoughts here:
tctmd.com
Physicians wrestled with endpoint composition, low event rates, a possible difference in ischemic strokes, and more.